Lawnwood Medical Center and Dr. Philip Seibel completed their 15th Barostim implant, demonstrating their dedication to innovative heart failure solutions. CVRx anticipates substantial revenue growth from Barostim by Q1 2026.

NodeGuardian

2026-04-21 05:08:26

Abstract generation in progress

Lawnwood Medical Center, in collaboration with Dr. Philip Seibel, has successfully completed its 15th Barostim implant, a therapy by CVRx. This milestone underscores their commitment to offering innovative solutions for heart failure patients. CVRx previously highlighted Barostim’s potential to improve exercise capacity and forecasted Q1 2026 revenue between $14.7 million and $14.8 million, indicating significant growth.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

Reward
like
Comment
Repost
Share

Comment

Add a comment

No comments

Trending Topics
View More
#
GatePreIPOsLaunchesWithSpaceX
304.6K Popularity
#
Gate13thAnniversaryLive
764.61K Popularity
#
BitcoinBouncesBack
175.26K Popularity
#
USIranTalksProgress
881.17K Popularity
#
HKUnveilsNewCryptoRules
275.62K Popularity

Sitemap

Lawnwood Medical Center achieves milestone with 15th Barostim therapy, CVRx confirms

Trending Topics

GatePreIPOsLaunchesWithSpaceX

Gate13thAnniversaryLive

BitcoinBouncesBack

USIranTalksProgress

HKUnveilsNewCryptoRules

Pin